{"id":"W2939988319","doi":"10.1200/jco.2015.33.15_suppl.e20094","title":"Evolution of BRAF gene mutation testing and treatment options in BRAF mutation carriers in Canada.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Vemurafenib; Trametinib; Medicine; Ipilimumab; Oncology; Internal medicine; Melanoma; Mutation; Cancer; Metastatic melanoma; Immunotherapy; Cancer research; Gene; MAPK/ERK pathway; Genetics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000467216,0.0002689791,0.000319022,0.00165005,0.001699584,0.001030674,0.0007851809,0.0005699639,0.002361448],"category_scores_gemma":[0.002327605,0.0003473207,0.0005504802,0.004990093,0.0006167946,0.0004033497,0.0006576982,0.0007110976,0.0002553144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02708044,"about_ca_system_score_gemma":0.03914795,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9860898,"about_ca_topic_score_gemma":0.9896622,"domain_scores_codex":[0.9990405,0.00004272249,0.00006222747,0.0001682122,0.0003397636,0.0003463856],"domain_scores_gemma":[0.9972391,0.0001406383,0.0009830631,0.00003841979,0.0009331923,0.0006656383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009123773,0.00002704923,0.9938962,0.00004842421,0.00002402819,0.0002822436,0.000318495,0.0001063592,0.0001788973,0.00008952723,0.001333555,0.003604012],"study_design_scores_gemma":[0.00000914494,0.0000327491,0.995213,0.00006062445,0.00002658849,0.0004977457,0.001387707,0.0003703599,0.0001093517,0.00003290859,0.002242041,0.00001775994],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830582,0.001806506,0.00008861341,0.0009693671,0.0000186152,0.00005728912,0.01108924,0.00001317587,0.002898958],"genre_scores_gemma":[0.9951915,0.0009664297,0.0001604274,0.0002570543,0.000009774034,0.00001582051,0.00265478,0.000007024983,0.0007373597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02708044,"threshold_uncertainty_score":0.1964833,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09995703269657306,"score_gpt":0.3796005499094474,"score_spread":0.2796435172128743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}